IL122974A - Optionally substituted tetrahydro-1H-naph[1,2,3-de]isoquinoline and pharmaceutical compositions containing them - Google Patents

Optionally substituted tetrahydro-1H-naph[1,2,3-de]isoquinoline and pharmaceutical compositions containing them

Info

Publication number: IL122974A
Authority: IL; Israel
Prior art keywords: naph; isoquinoline; optionally substituted; pharmaceutical compositions; compositions containing
Prior art date: 1995-08-18

Application number

IL12297496A

Other languages

English (en)

Other versions

IL122974A0 (en

Original Assignee

Purdue Research Foundation

Univ North Carolina

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-08-18

Filing date

1996-08-16

Publication date

2000-11-21

1996-08-16 Application filed by Purdue Research Foundation, Univ North Carolina filed Critical Purdue Research Foundation

1998-08-16 Publication of IL122974A0 publication Critical patent/IL122974A0/xx

2000-11-21 Publication of IL122974A publication Critical patent/IL122974A/xx

Links

239000008194 pharmaceutical composition Substances 0.000 title abstract 2
AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 title 2
150000001875 compounds Chemical class 0.000 abstract 2
VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 abstract 2
102000015554 Dopamine receptor Human genes 0.000 abstract 1
108050004812 Dopamine receptor Proteins 0.000 abstract 1
210000003169 central nervous system Anatomy 0.000 abstract 1
229960003638 dopamine Drugs 0.000 abstract 1
230000004064 dysfunction Effects 0.000 abstract 1
239000003446 ligand Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
210000001428 peripheral nervous system Anatomy 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/18—Ring systems of four or more rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Other In-Based Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Peptides Or Proteins (AREA)

IL12297496A 1995-08-18 1996-08-16 Optionally substituted tetrahydro-1H-naph[1,2,3-de]isoquinoline and pharmaceutical compositions containing them IL122974A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US251995P	1995-08-18	1995-08-18
PCT/US1996/013416 WO1997006799A1 (fr)	1995-08-18	1996-08-16	Nouvelles isoquinoleines fusionnees utilisees en tant que ligands pour recepteurs de la dopamine

Publications (2)

Publication Number	Publication Date
IL122974A0 IL122974A0 (en)	1998-08-16
IL122974A true IL122974A (en)	2000-11-21

Family

ID=21701148

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL12297496A IL122974A (en)	1995-08-18	1996-08-16	Optionally substituted tetrahydro-1H-naph[1,2,3-de]isoquinoline and pharmaceutical compositions containing them

Country Status (18)

Country	Link
US (2)	US5959110A (fr)
EP (1)	EP0845988B1 (fr)
JP (1)	JP2000505046A (fr)
CN (1)	CN1199338A (fr)
AT (1)	ATE209915T1 (fr)
AU (1)	AU700688B2 (fr)
BR (1)	BR9610323A (fr)
CA (1)	CA2227585A1 (fr)
DE (1)	DE69617700T2 (fr)
DK (1)	DK0845988T3 (fr)
ES (1)	ES2169257T3 (fr)
IL (1)	IL122974A (fr)
MX (1)	MX9801179A (fr)
NO (1)	NO308658B1 (fr)
NZ (1)	NZ316312A (fr)
PT (1)	PT845988E (fr)
RU (1)	RU2177001C2 (fr)
WO (1)	WO1997006799A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU700688B2 (en) *	1995-08-18	1999-01-14	Purdue Research Foundation	Novel fused isoquinolines as dopamine receptor ligands
KR20030027020A (ko) *	2000-08-11	2003-04-03	펄듀 리서치 파운데이션	디나프솔린의 제조 공정
MXPA03006265A (es) *	2001-01-16	2004-06-25	Purdue Research Foundation	Metodo de tratamiento de disfuncion relacionada con dopamina mediante administracion de un agonista de receptor de dopamina d1 completo, sin generacion de tolerancia.
DE60220800D1 (de) *	2001-08-10	2007-08-02	Purdue Research Foundation	Chirales dinapsolin
AU2003217430B2 (en) *	2002-02-15	2008-10-23	Darpharma, Inc.	Mono-ester and asymmetrically substituted Di-ester pro-drugs of the dopamine D1 receptor agonists
JP2004190007A (ja) *	2002-11-27	2004-07-08	Konica Minolta Holdings Inc	色素およびインクジェット記録液
WO2005029077A1 (fr) *	2003-09-24	2005-03-31	Biacore Ab	Procede et systeme d'analyse d'interactions moleculaires
WO2007098462A2 (fr) *	2006-02-21	2007-08-30	Purdue Research Foundation	Synthèse et méthodes d'utilisation de chroménoisoquinolines trans-fusionnées
RS53866B1 (sr) *	2008-07-16	2015-08-31	Richter Gedeon Nyrt.	Farmaceutske formulacije koje sadrže ligande dopaminskih receptora
US9359303B2 (en)	2009-04-21	2016-06-07	Purdue Research Foundation	Octahydrobenzoisoquinoline modulators of dopamine receptors and uses therefor
CN110068645B (zh) *	2019-04-03	2021-09-03	上海药明奥测医疗科技有限公司	液质联用检测尿液中环磷酸腺苷的方法
CA3148598A1 (fr)	2019-07-30	2021-02-04	Mayo Foundation For Medical Education And Research	Composes et methodes de traitement de pathologies fibrotiques
WO2022164996A1 (fr) *	2021-01-29	2022-08-04	Mayo Foundation For Medical Education And Research	Méthodes de traitement de pathologies fibrotiques oculaires

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4346090A (en) *	1977-07-21	1982-08-24	Ayerst, Mckenna & Harrison Ltd.	13-Chloro-benzocycloheptapyridoisoquinolines and use as neuroleptics
HU180234B (en) *	1979-01-22	1983-02-28	Lilly Co Eli	Process for producing oktahydro-pyrasolo-aracket-3,4-g-bracket closed-quinolines
DE3624607A1 (de) *	1986-07-21	1988-01-28	Boehringer Ingelheim Kg	Neue tetrahydrobenzothiazolo-chinoline ihre herstellung und verwendung
US4902695A (en) *	1989-02-13	1990-02-20	Eli Lilly And Company	Excitatory amino acid receptor antagonists
US5047536A (en) *	1989-03-17	1991-09-10	Purdue Research Foundation	Hexahydrobenzo(A)phenanthridine compounds
IE912999A1 (en) *	1990-09-07	1992-03-11	Abbott Lab	Phenanthridine compounds
CA2054569A1 (fr) *	1990-11-07	1992-05-08	Masanobu Suzuki	Procede pour la preparation de derives du benzo¬c\|phenanthridinium, et nouveaux composes prepares suivant ce procede
AU4391493A (en) *	1992-05-26	1993-12-30	Purdue Research Foundation	Substituted-hexahydrobenzo(A)phenanthridines
AU700688B2 (en) *	1995-08-18	1999-01-14	Purdue Research Foundation	Novel fused isoquinolines as dopamine receptor ligands

1996
- 1996-08-16 AU AU68513/96A patent/AU700688B2/en not_active Ceased
- 1996-08-16 WO PCT/US1996/013416 patent/WO1997006799A1/fr not_active Ceased
- 1996-08-16 ES ES96928941T patent/ES2169257T3/es not_active Expired - Lifetime
- 1996-08-16 PT PT96928941T patent/PT845988E/pt unknown
- 1996-08-16 MX MX9801179A patent/MX9801179A/es not_active IP Right Cessation
- 1996-08-16 IL IL12297496A patent/IL122974A/xx not_active IP Right Cessation
- 1996-08-16 RU RU98104276/14A patent/RU2177001C2/ru active
- 1996-08-16 DK DK96928941T patent/DK0845988T3/da active
- 1996-08-16 JP JP9509550A patent/JP2000505046A/ja not_active Ceased
- 1996-08-16 NZ NZ316312A patent/NZ316312A/xx not_active IP Right Cessation
- 1996-08-16 CA CA002227585A patent/CA2227585A1/fr not_active Abandoned
- 1996-08-16 EP EP96928941A patent/EP0845988B1/fr not_active Expired - Lifetime
- 1996-08-16 AT AT96928941T patent/ATE209915T1/de not_active IP Right Cessation
- 1996-08-16 CN CN96197477A patent/CN1199338A/zh active Pending
- 1996-08-16 DE DE69617700T patent/DE69617700T2/de not_active Expired - Fee Related
- 1996-08-16 BR BR9610323-0A patent/BR9610323A/pt not_active IP Right Cessation
- 1996-08-16 US US08/727,451 patent/US5959110A/en not_active Expired - Lifetime
1998
- 1998-02-18 NO NO980688A patent/NO308658B1/no unknown
1999
- 1999-08-13 US US09/374,423 patent/US6194423B1/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
AU700688B2 (en)	1999-01-14
AU6851396A (en)	1997-03-12
PT845988E (pt)	2002-05-31
RU2177001C2 (ru)	2001-12-20
NZ316312A (en)	1999-06-29
ES2169257T3 (es)	2002-07-01
EP0845988A4 (fr)	1998-11-11
EP0845988B1 (fr)	2001-12-05
DE69617700T2 (de)	2002-07-18
DE69617700D1 (de)	2002-01-17
NO980688D0 (no)	1998-02-18
CN1199338A (zh)	1998-11-18
US5959110A (en)	1999-09-28
MX9801179A (es)	1998-04-30
DK0845988T3 (da)	2002-04-02
WO1997006799A1 (fr)	1997-02-27
BR9610323A (pt)	1999-12-21
EP0845988A1 (fr)	1998-06-10
US6194423B1 (en)	2001-02-27
ATE209915T1 (de)	2001-12-15
IL122974A0 (en)	1998-08-16
JP2000505046A (ja)	2000-04-25
NO308658B1 (no)	2000-10-09
CA2227585A1 (fr)	1997-02-27
NO980688L (no)	1998-02-18

Similar Documents

Publication	Publication Date	Title
PL320822A1 (en)	1998-01-05	Sulphonamidic compounds as therapeutic agents for treatment of central nervous system, method of obtaining novel sulphonamidic compounds and drugs containing such compounds
IL127244A (en)	2005-11-20	Substituted amines, methods of their preparation and pharmaceutical compositions containing them
IL122974A (en)	2000-11-21	Optionally substituted tetrahydro-1H-naph[1,2,3-de]isoquinoline and pharmaceutical compositions containing them
IL81234A (en)	1992-09-06	Peptidylaminodiols,process for their preparation and pharmaceutical compositions comprising them
AP9600804A0 (en)	1997-11-09	Therapeutic amides.
MY121047A (en)	2005-12-30	Bicyclo [2.2.1] heptanes and related compounds
CA2252515A1 (fr)	1997-10-30	Preparations pharmaceutiques pour la prevention et le traitement de troubles du systeme nerveux central
GR3017996T3 (en)	1996-02-29	17-g(b)-SUBSTITUTED-4-AZA-5-g(a)-ANDROSTAN-3-ONE DERIVATIVES AND PROCESS FOR THEIR PREPARATION.
IL112957A0 (en)	1995-06-29	Thieno [2,3-b] indoles, their preparation and pharmaceutical compositions containing them
NZ302159A (en)	2000-01-28	Tricyclic benzazepine derivatives and medicaments
PL330207A1 (en)	1999-04-26	Aryl-substituted cyclic amines as selective ligands of d 3 dopamine
MX9706605A (es)	1998-02-28	Derivados de indol como antagonistas de los aminoacidos exitadores.
GB9212308D0 (en)	1992-07-22	Therapeutic compositions
MX9806171A (es)	1998-10-31	Derivados 2,3-benzodiazepina y sus usos como inhibidores del receptor-ampa.
GR3034354T3 (en)	2000-12-29	IMIDAZO 1,2-a]QUINOXALIN-4-AMINES ACTIVE AS ADENOSINE ANTAGONISTS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THEREOF
MX9708557A (es)	1997-12-31	Nuevo uso farmacologico de los antagonistas del receptor aii.
AU5644296A (en)	1996-11-21	Novel heterocyclic chemistry
BG101929A (en)	1998-04-30	Benzamides for neurodegenerative disorder treatment
NZ320522A (en)	1999-03-29	Piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same and a process for the preparation of the compounds
UA48962C2 (uk)	2002-09-16	Біциклічні антагоністи тахікінінів, фармацевтична композиція та спосіб лікування
UA41981C2 (uk)	2001-10-15	Біотинові сполуки, спосіб їх отримання, фармацевтична композиція та спосіб її отримання
MXPA98005355A (es)	2004-10-28	Derivados de 5-[(heteroaril) alquil]-3 -oxo-pirido [1, 2-a]bencimidazol -4-carboxamida utiles en el tratamiento de trastornos del sistema nervioso central.
ES2013391A6 (es)	1990-05-01	Procedimiento para la preparacion de derivados acetilenicos y alenicos de 2-aminometil -5-metoxiindoles.
MX9703610A (es)	1998-06-30	Nuevas (5,6)-heteroaril condensado-pirimidin-4-onas 2,3 disustituidas.
PT950053E (pt)	2003-10-31	Novos derivados de benzoilalquil-1,2,3,6-tetra-hidropiridinas

Legal Events

Date	Code	Title
2001-04-30	FF	Patent granted
2001-07-24	KB	Patent renewed
2002-11-10	KB	Patent renewed
2006-10-30	KB	Patent renewed
2010-11-30	KB	Patent renewed
2015-03-31	MM9K	Patent not in force due to non-payment of renewal fees